addressalign-toparrow-leftarrow-rightbackbellblockcalendarcameraccwcheckchevron-downchevron-leftchevron-rightchevron-small-downchevron-small-leftchevron-small-rightchevron-small-upchevron-upcircle-with-checkcircle-with-crosscircle-with-pluscontroller-playcrossdots-three-verticaleditemptyheartexporteye-with-lineeyefacebookfolderfullheartglobegmailgooglegroupshelp-with-circleimageimagesinstagramFill 1launch-new-window--smalllight-bulblinklocation-pinm-swarmSearchmailmessagesminusmoremuplabelShape 3 + Rectangle 1ShapeoutlookpersonJoin Group on CardStartprice-ribbonprintShapeShapeShapeShapeImported LayersImported LayersImported Layersshieldstartickettrashtriangle-downtriangle-uptwitteruserwarningyahoo

What are life sciences VCs looking for?

From: user 1.
Sent on: Monday, August 23, 2010 1:29 PM

The average Venture Capitalist or angel investor listens to uncounted pitches by entrepreneurs hoping to gain access to funding. The key to success in obtaining financial backing for your life sciences or healthcare focused startup is to learn how to differentiate yourself from the pack. The innovative nature of a new medical device, drug or service is not enough to secure funding; you have to understand how to appeal to the interests of your potential investors as well.


The 2010 Life Sciences & Healthcare Venture Summit is the premier venue for connecting with VCs, corporate VCs, angel investors and investment bankers for the CEOs of early stage and emerging growth companies in the fields of biotech, pharmaceuticals, healthcare, medical devices, healthcare IT and diagnostics.


Aside from connecting with many of the leading VCs in the life sciences sector, and, if chosen, presenting your innovations to a large crowd of top investors, you will learn directly from the VCs themselves how to pitch your company.


Over 35 leading VCs will be featured on multiple panel discussions about their investment criteria and current and future industry trends. There will also be over 50 Top Innovator presentations by future industry leaders and high-level networking opportunities.


A partial list of VCs confirmed to speak includes:

Gaurav Aggarwal, MD, Principal, Panorama Capital | Eric Aguiar, Partner, Thomas, McNerney and Partners | Richard Anders, Founder, Executive Director, Mass Medical Angels | Michael Balmuth, General Partner, Edison Venture Fund | Daniel Bertholet, Investment Director, Endeavour Vision | Gerry Brunk, Managing Director, Lumira Capital | Mike Bunker, Managing Director, Early Stage Partners | Dana Callow, Managing General Partner, Boston Millennia Partners | Mary Lincoln Campbell, Managing Director, EDF Ventures | Max C. Chee, Principal, Millennium Technology Ventures | Rajeev Dadoo, PhD, Partner, SR One | John A. Deedrick, Managing Director, Accuitive Medical Venture | Jon Edelson, MD, Venture Partner, Ascent Biomedical Ventures | David Eichler, Managing Member, Psilos Group Managers | Neil A. Exter, Partner, Third Rock Ventures | Teo Forcht Dagi, Partner, HLM Venture Partners | Dr. Andrew T. Jay, Managing Partner- Healthcare, Siemens Venture Capital | John Giannuzzi, Managing General Partner, Sherbrooke Capital | Myles D. Greenberg, M.D., Partner, CHL Medical Partners | Mudit Jain, Ph.D., Partner, Synergy Life Sciences Partners | Christine Karslake, PhD, MBA, Leader, New Ventures Group, Sigma-Aldrich | Curt LaBelle, MD, Managing Director, Tullis Health Investors | Albert A. Lauritano, MSc, CLP, Director / Business Development, BD Technologies | Douglas Lind, Managing Partner, GBP Capital | Allan W. May, Managing Director, Emergent Medical Partners | Vincent J. Miles PhD, Venture Partner, Abingworth | Tony Natale, M.D., Venture Partner, Prism VentureWorks | R. Matthew Neff, President and CEO, Clarian Health Ventures | Mina Patel Sooch, MBA, General Partner, Apjohn Ventures & Triathlon Ventures | Jim Peters, Managing Partner, Geisinger Ventures | Joshua S. Phillips, Managing General Partner, Catalyst Health Ventures | Liam Ratcliffe MD PhD, Venture Partner, New Leaf Partners | Philip Sanger, M. D., Managing Partner, TEXO Ventures | Lauren Silverman, Ph.D., Managing Director, Novartis BioVentures | Chris Varma, Partner, Flagship Ventures | Tracy S. Warren, General Partner, Battelle Ventures | Daniel C. Wood, CFA, General Partner, Mesa Verde Venture Partners | David Wurzer, Managing Director, Investments, Connecticut Innovations and many more.


Find the summit online at and contact [address removed] if you would like to apply to present

People in this
Meetup are also in:

Sign up

Meetup members, Log in

By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy